Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.
about
Clonal origin and spread of metastatic prostate cancerThe mutational landscape of prostate cancerBiologic and clinical significance of androgen receptor variants in castration resistant prostate cancerStructural variation discovery in the cancer genome using next generation sequencing: computational solutions and perspectivesInternational Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptorsAbnormal dosage of ultraconserved elements is highly disfavored in healthy cells but not cancer cellsGene Expression Differences in Prostate Cancers between Young and Old MenFindings made in gene panel to whole genome sequencing: data, knowledge, ethics - and consequences?Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Androgen regulation of the TMPRSS2 gene and the effect of a SNP in an androgen response elementFamily with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentSystematic identification and characterization of RNA editing in prostate tumors.Molecular pathways and targets in prostate cancerImpact of soy isoflavones on the epigenome in cancer prevention.PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesisFISH Oracle 2: a web server for integrative visualization of genomic data in cancer research.Role of non-coding sequence variants in cancer.Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges and Chances in Prostate Cancer Research Meeting 2013".Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.Genomic rearrangements in prostate cancer.Constitutive activity of the androgen receptor.Crosstalking between androgen and PI3K/AKT signaling pathways in prostate cancer cells.Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells.Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionHigh-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate CancerHOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyHeterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.Defining order and timing of mutations during cancer progression: the TO-DAG probabilistic graphical modelAndrogen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.Tissue-specific tumorigenesis: context matters.Predictive Modeling of Drug Treatment in the Area of Personalized Medicine.Tonic suppression of PCAT29 by the IL-6 signaling pathway in prostate cancer: Reversal by resveratrolA novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotationsTranslational and clinical implications of the genetic landscape of prostate cancer.
P2860
Q26752873-924089DB-C41F-47AE-AC0A-BC050E1782B2Q26851631-433D4011-02A4-45B0-9F2B-4A39A5A68F2CQ26858922-9518B73B-FCC1-4E80-8C25-98BC2CDD740CQ26991436-2DFF0538-7046-4949-A143-B15906425380Q28257710-E3BCCFFE-BEA4-4E80-90CF-C1151D328997Q28396411-07C359EF-8E85-4CE1-AC92-46E8B7E4925AQ28468529-697CE8E3-7DF9-4FAF-9CF1-2DE5B00EBC4BQ31114379-A59C57CE-5DCF-4C33-AA66-11B9F8C3D0F9Q33640983-9DB6C48F-75FD-4536-B321-F3365E869955Q33663401-9ECC88A8-B61F-4842-9899-124CC6CB8D6FQ33761801-1CACAFE4-B7FD-473C-ADEB-FF5BEAE77848Q33850638-907A1BD7-C387-4D7B-9297-44DC7D8E60E8Q33852664-7C38958C-DEF9-4CB8-8A7E-189B57CA68E5Q33921151-7DDF3F82-1FBF-484E-B36A-E342FFAECFFFQ34365632-C66E35FE-4CDF-4CB0-8FB5-2B079ADB6448Q34411665-273A2E6F-8A91-4E71-A5DB-354A4BDDC867Q34434937-152984FF-5AC1-43CB-8892-CEBBFC933323Q34504704-0AC625A8-47C6-454C-9F16-1485162AAA87Q34509633-25CFD863-A9CE-4533-B5F2-2B484A89E2B7Q34528219-A72A28BF-6159-4091-9CEE-563671286596Q34545220-2D5BD3A3-19A9-4FD3-BFAA-374AE924D6E6Q34722101-A34C6053-3CA7-4431-895C-5D7084DDEA75Q34775572-C56F3A00-A191-4480-AB50-C4099AF1E087Q35048965-18F2D1E0-74CE-4A85-8436-5F3B073CE2E4Q35108540-6D7C91F1-BF3C-49C2-9230-66F2C708FC03Q35168191-1B945D2A-B9D8-48BF-909A-1855BD0648A3Q35235374-E16EE58D-B011-4A7B-88E5-52450DED0E91Q35407284-77C2F50B-4BE8-4817-A3D3-888F798D61A4Q35706611-7538FDE7-D2A5-4BC4-9C67-922D5ABD1BFAQ35731092-6D6745A5-F4FD-4C99-A105-1EC18D50A54CQ35828702-A552C3D8-2BC2-439E-AE4C-A6624B8F1CCBQ36105102-FB362770-C4AA-4B97-B40F-C3C372B228DBQ36149716-052BF261-9F69-4F5B-A223-33A30CD24DA4Q36189798-8055F401-C79D-45DB-A943-93425F637E5AQ36296335-0D3A7C49-FE5C-48C7-B1A4-49C9DF0A5D92Q36351777-C448B0EF-EC45-4511-9FF3-DF40C4E29A7CQ36361936-61A73226-F14C-41F3-9AC6-41CBB9A503C2Q36437601-9F175CDB-6AD7-4FDF-8D7B-F4844720118BQ36676636-C8F95530-32F3-42B6-B09E-E67A98B69666Q37270512-ECEA777D-6CCD-422E-9073-4D4E8ACBF121
P2860
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Integrative genomic analyses r ...... n early-onset prostate cancer.
@en
Integrative genomic analyses r ...... n early-onset prostate cancer.
@nl
type
label
Integrative genomic analyses r ...... n early-onset prostate cancer.
@en
Integrative genomic analyses r ...... n early-onset prostate cancer.
@nl
prefLabel
Integrative genomic analyses r ...... n early-onset prostate cancer.
@en
Integrative genomic analyses r ...... n early-onset prostate cancer.
@nl
P2093
P50
P1433
P1476
Integrative genomic analyses r ...... n early-onset prostate cancer.
@en
P2093
Adrian M Stütz
Antje Krohn
Christian Lawerenz
Christoph Plass
Constance Baer
Cynthia C Bartholomae
Daniela Wuttig
Dieter Weichenhan
Dmitri Parkhomchuk
Guido Sauter
P304
P356
10.1016/J.CCR.2013.01.002
P50
P577
2013-02-01T00:00:00Z